Leica Biosystems and Advanced Cell Diagnostics Inc (ACD) have announced the co-marketing of ACD's RNAscope LS ISH assays with Leica Biosystems' BOND RX research staining platform*. This agreement provides researchers with an integrated and fully automated ISH solution. The market-leading RNAscope LS reagent kits and ISH probes are available from ACD while the BOND RX instrument and associated reagents are supplied by Leica Biosystems.
ACD's RNAscope assays represent a technological advance for in situ RNA detection. For the first time, robust single RNA molecule detection is available for formalin-fixed, paraffin-embedded (FFPE) tissue.
The RNAscope LS assays are fully automated on the BOND RX platform. This open and flexible system automates staining to provide a fast, high-throughput workflow with exceptional consistency and minimal hands-on time.
*For research use only. Not for use in diagnostic procedures.
